Mandate

VINGE ADVISES FIDELIO CAPITAL IN CONNECTION WITH NORDIC CAPITAL’S INVEStMENT IN ANICURA

July 01, 2014

Vinge advises Fidelio Capital in connection with Nordic Capital’s investment in AniCura. AniCura is owned by a large number of staff, the Foundation Djursjukhus i Stor-Stockholm and the Swedish investment firm Fidelio Capital. All parties will remain significant co-owners together with Nordic Capital. Through Nordic Capital’s co-ownership, resources will be made available for, among other things, establishing a new veterinary specialist neurological centre at AniCura Albano Animal Hospital in Danderyd, Sweden. Nordic Capital’s investment is subject to approval from the relevant competition authorities.

Partners Jonas Bergström and Johan Winnerblad together with, among others, associates Peter Sundgren, Gustav Jönsson, Amanda Winberg, Johan Mattson, Emelie Klefbeck and project assistant Pernilla Warg advises Fidelio Capital. Partner Marcus Glader advises on competition law.

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026